Navigation Links
MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
Date:9/18/2007

3.0T Endorectal Coil for Prostate MR Now Available for All Three Major MR

Scanner Manufacturers

WARRENDALE, Pa., Sept. 18 /PRNewswire/ -- MEDRAD today announced the availability of the 3.0T Prostate eCoil (TM) MR Endorectal Coil compatible with magnetic resonance (MR) scanners made by Philips and Siemens. MEDRAD introduced the 3.0T prostate eCoil for GE scanners in 2006.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040309/MEDRADLOGO )

"High-resolution prostate MR imaging is important to many people, especially to the hundreds of thousands of men who are diagnosed with prostate cancer each year," said Joe Havrilla, senior vice president, MEDRAD MR Business Unit. "By developing the eCoil for all three major scanner platforms, we increase patient access to prostate MR, an emerging new imaging procedure for early diagnosing and staging of prostate cancer."

The 3.0T Prostate eCoil conforms to the size and shape of the prostate for consistent contact between the gland and the signal-amplifying elements of the coil. The result is small field-of-view (FOV) and high spatial resolution, sensitivity, and specificity that yield clearer pictures of the prostate. These pictures provide information needed by clinicians to diagnose and stage cancer, and also to plan and deliver targeted treatment, such as radiation therapy.

Professor Jelle Barentsz, University Medical Center -- Nijmegan, The Netherlands, has used the MEDRAD eCoil on a Siemens 3.0T MR scanner for several years. "Using the endorectal coil at 3.0T results in such an enormous gain in spatial resolution that accurate detection of extracapsular tumor growth, in the millimeter range, is possible," said Barentsz.

Dr. Adam J. Jung, PI Prostate Imaging Group, University of Texas Health Sciences Center San Antonio, is using the MEDRAD eCoil on the Philips 3.0T Achieva MR scanner. "Combined endorectal coil and phased array imaging of prostate cancer at 3.0T provides robust prostate cancer depiction with dramatically improved anatomic spatial resolution, dynamic temporal resolution, and MRS metabolite dispersion," Jung said. "The result is likely improvements to both staging and image-based management of early prostate cancer."

The Prostate eCoil is also available for 1.5T magnet strength environments and is one of MEDRAD's Leading Image(TM) MR Coil products.

MEDRAD offers more information on the Prostate eCoil on the corporate Website at http://www.medrad.com/products/mr/mr-coils/ecoil.html.

MEDRAD, INC. is a worldwide leading provider of medical devices and services that enable and enhance imaging procedures of the human body. Used in diagnostic imaging, MEDRAD's product offerings include a comprehensive line of vascular injection systems, magnetic resonance (MR) surface coils and patient care products, and equipment services. Total 2006 revenues were $478 million. MEDRAD is a 2003 recipient of the Malcolm Baldrige National Quality Award, the top honor a U.S. company can receive for quality and business excellence. The company's world headquarters is near Pittsburgh, Pennsylvania, in the United States. MEDRAD is an affiliate of Bayer AG. More company information is available at http://www.medrad.com.

The Bayer Group is a global enterprise with core competencies in the fields of healthcare, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma AG. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at http://www.bayerhealthcare.com.

Cautionary statement regarding forward-looking statements.

Certain statements in this press release that are neither reported financial results nor other historical information are forward-looking statements, including but not limited to, statements that are predictions of or indicate future events, trends, plans or objectives. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results and MEDRAD's plans and objectives to differ materially from those expressed or implied in the forward-looking statements. MEDRAD, INC. undertakes no obligation to update publicly or revise any of these forward-looking statements, whether to reflect new information or future events or circumstances or otherwise.


'/>"/>
SOURCE MEDRAD, INC.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/26/2016)... PLAINSBORO, N.J. (PRWEB) , ... June 27, 2016 , ... ... same sources, yet in many ways they remain in the eye of the beholder, ... Oncology (EBO), a publication of The American Journal of Managed Care. For the full ...
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Procedure Volumes: Global Analysis (United States, China, Japan, Brazil, ... report to their offering. ... for healthcare business planners, provides surgical procedure volume data ... trends with an in-depth analysis of growth drivers and ...
(Date:6/23/2016)... NEW YORK , June 23, 2016 ... rough waters, but it continues to present great opportunities ... featured companies for today: Intrexon Corp. (NYSE: ... ), Arena Pharmaceuticals Inc. (NASDAQ: ARNA ), ... Learn more about these stocks and receive your complimentary ...
(Date:6/23/2016)... Leading BioSciences Inc., a clinical-stage biopharmaceutical ... from a breakdown of the mucosal barrier, today ... as chief executive officer. Mr. Doyle, a ... and board of directors, previously served as chief ... provide continued leadership and strategic direction to the ...
Breaking Medicine Technology: